Answered step by step
Verified Expert Solution
Question
1 Approved Answer
Forecast Income Statement and Balance Sheet Following are the income statement and balance sheet for Medtronic PLC. Consolidated Statement of Income, 12 Months Ended ($
Forecast Income Statement and Balance Sheet
Following are the income statement and balance sheet for Medtronic PLC.
Consolidated Statement of Income, 12 Months Ended ($ millions) | April 26, 2019 |
---|---|
Net Sales | $30,557 |
Costs and expenses | |
Cost of products sold | 9,155 |
Research and development expense | 2,330 |
Selling, general, and administrative expense | 10,418 |
Amortization of intangible assets | 1,764 |
Restructuring charges, net | 198 |
Certain litigation charges | 166 |
Other operating expense, net | 258 |
Operating profit | 6,268 |
Other nonoperating income, net | 373 |
Interest expense | 1,444 |
Income before income taxes | 5,197 |
Income tax provision | 547 |
Net income | 4,650 |
Net income attributable to noncontrolling interests | 19 |
Net income attributable to Medtronic | $ 4,631 |
Consolidated Balance Sheet ($ millions) | April 26, 2019 |
---|---|
Current assets | |
Cash and cash equivalents | $ 4,393 |
Investments | 5,455 |
Accounts receivable, less allowances of $190 | 6,222 |
Inventories, net | 3,753 |
Other current assets | 2,144 |
Total current assets | 21,967 |
Property, plant, and equipment, net | 4,675 |
Goodwill | 39,959 |
Other intangible assets, net | 20,560 |
Tax assets | 1,519 |
Other assets | 1,014 |
Total assets | $89,694 |
Current liabilities | |
Current debt obligations | $838 |
Accounts payable | 1,953 |
Accrued compensation | 2,189 |
Accrued income taxes | 567 |
Other accrued expenses | 2,925 |
Total current liabilities | 8,472 |
Long-term debt | 24,486 |
Accrued compensation and retirement benefits | 1,651 |
Accrued income taxes | 2,838 |
Deferred tax liabilities | 1,278 |
Other liabilities | 757 |
Total liabilities | 39,482 |
Shareholders' equity | |
Ordinary shares | 0 |
Additional paid-in capital | 26,532 |
Retained earnings | 26,270 |
Accumulated other comprehensive loss | (2,711) |
Total shareholders' equity | 50,091 |
Noncontrolling interests | 121 |
Total equity | 50,212 |
Total liabilities and shareholders' equity | $89,694 |
Use the following assumptions to prepare a forecast of the companys income statement for fiscal year 2020.
Net sales increase | 8% |
Cost of product sold | 30.0% of net sales |
Research and development expense | 7.6% of net sales |
Selling, general, and administrative expense | 34.1% of net sales |
Amortization of intangible assets | 5.8% of net sales |
Restructuring charges, net | 75% of 2019 expense |
Certain litigation charges | $150 million |
Other operating expense, net | No change |
Interest expense | No change |
Income tax provision | 15% of pre-tax income |
Income to noncontrolling interests | No change |
- Round answers to the nearest whole number.
- Do not use negative signs with any of your answers.
Consolidated Statement of Income, 12 Months Ended ($ millions) | April 2020 |
---|---|
Net Sales | Answer |
Costs and expenses | |
Cost of products sold | Answer |
Research and development expense | Answer |
Selling, general, and administrative expense | Answer |
Amortization of intangible assets | Answer |
Restructuring charges, net | Answer |
Certain litigation charges | Answer |
Other operating expense, net | Answer |
Operating profit | Answer |
Other nonoperating income, net | Answer |
Interest expense | Answer |
Income before income taxes | Answer |
Income tax provision | Answer |
Net income | Answer |
Net income attributable to noncontrolling interests | Answer |
Net income attributable to Medtronic | Answer |
Use the following assumptions to prepare a forecast of the companys balance sheet for fiscal year 2020.
Accounts receivable, less allowances | 20.4% of net sales |
Inventories, net | 12.3% of net sales |
Other current assets | 7% of net sales |
Goodwill | No change |
Tax assets | 5% of net sales |
Other assets | 3.3% of net sales |
Accounts payable | 6.4% of net sales |
Accrued compensation (current liability) | 7.2% of net sales |
Accrued income taxes (current liability) | 1.9% of net sales |
Accrued income taxes (noncurrent liability) | 9.3% of net sales |
Other accrued expenses | 9.6% of net sales |
Accrued compensation and retirement benefits (noncurrent liability) | No change |
Deferred tax liabilities | 4.2% of net sales |
Other liabilities | 2.5% of net sales |
Ordinary shares | No change |
Accumulated other comprehensive loss | No change |
Net income attributable to noncontrolling interest | $19 million |
Dividends in FY2020 | $2,853 million |
CAPEX in FY2019, forecast CAPEX at historic % of net sales | $1,134 million |
Depreciation expense in FY2020 | $950 million |
Amortization expense in FY2020 | $1,914 million |
Debt due in FY2020 | $838 million |
Debt due in FY2021 | $2,058 million |
- Round answers to the nearest whole number.
- Use a negative sign with your Accumulated other comprehensive loss answer.
Consolidated Balance Sheet ($ millions) | April 2020 |
---|---|
Current assets | |
Cash and cash equivalents | Answer |
Investments | Answer |
Accounts receivable, less allowances of $190 | Answer |
Inventories, net | Answer |
Other current assets | Answer |
Total current assets | Answer |
Property, plant, and equipment, net | Answer |
Goodwill | Answer |
Other intangible assets, net | Answer |
Tax assets | Answer |
Other assets | Answer |
Total assets | Answer |
Current liabilities | |
Current debt obligations | Answer |
Accounts payable | Answer |
Accrued compensation | Answer |
Accrued income taxes | Answer |
Other accrued expenses | Answer |
Total current liabilities | Answer |
Long-term debt | Answer |
Accrued compensation and retirement benefits | Answer |
Accrued income taxes | Answer |
Deferred tax liabilities | Answer |
Other liabilities | Answer |
Total liabilities | Answer |
Shareholders' equity | |
Ordinary shares | Answer |
Additional paid-in capital | Answer |
Retained earnings | Answer |
Accumulated other comprehensive loss | Answer |
Total shareholders' equity | Answer |
Noncontrolling interests | Answer |
Total equity | Answer |
Total liabilities and shareholders' equity | Answer |
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started